Lawrence Eichenfield, MD, outlines a patient-centered approach to atopic dermatitis, assessing disease history, life impact, and prior therapy use.

D-VRd is the only quadruplet regimen approved for patients with newly diagnosed multiple myeloma, irrespective of transplant ...

The American Academy of Pediatrics (AAP) released its 2026 child and adolescent immunization schedule, which continues to ...

Experts discuss groundbreaking therapies in dermatology at Maui Derm 2026, addressing complex skin diseases and enhancing patient care with innovative treatments.

The CDC's revised schedule reduces routine vaccines from 17 to 11 diseases, with some vaccines now for high-risk groups or under shared decision-making. Experts criticize the lack of transparency and ...

To set the stage for this milestone issue, Apathy reflects on the most significant health IT advancements of the past 15 ...

ICE presence in health care settings is causing fear and healthcare avoidance, particularly among Hispanic/Latino and Somali ...

CMS released its 2027 Advance Notice of Methodological Changes for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies, proposing a net average year-over-year payment ...

A Michigan-based deliberative study found strong public support for patient-informed artificial intelligence (AI) labeling in health care, emphasizing transparency, privacy, equity, and safety to ...

A letter from the guest editor introduces this year’s Health Information Technology issue, which explores 4 key themes driving health care’s digital transformation from basic automation to ...

Paul Nghiem, MD, PhD, discusses individualized therapies and the evolving role of AI in improving outcomes for actinic keratosis and related skin conditions.

The CDC announced that recommendations for vaccines for respiratory syncytial virus, hepatitis A, hepatitis B, dengue, and 2 types of bacterial meningitis were rolled back. 2 The vaccinations for flu, ...